222 related articles for article (PubMed ID: 30768)
21. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
Lipman R; Vanov SK; Richards DJ
Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
[No Abstract] [Full Text] [Related]
22. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
Bertin I; Colombo G; Furlanut M; Benetello P
Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
[TBL] [Abstract][Full Text] [Related]
23. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
Ruiz AT
J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
[TBL] [Abstract][Full Text] [Related]
25. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
Zung WW; Daniel JT; King RE; Moore DT
J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
[TBL] [Abstract][Full Text] [Related]
26. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
[TBL] [Abstract][Full Text] [Related]
27. Lorazepam and diazepam in the treatment of neurotic anxiety: a double-blind trial.
Valarino F; Perez-Lopez R
Dis Nerv Syst; 1976 Feb; 37(2):58-61. PubMed ID: 1213
[TBL] [Abstract][Full Text] [Related]
28. [Use of an anxiolytic agent (lorazepam) in low doses in the treatment of anxiety states].
Bocci U; Inga EF; Luzi T
Minerva Med; 1977 Jul; 68(36):2517-22. PubMed ID: 18689
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
[TBL] [Abstract][Full Text] [Related]
30. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
Samuelian JC; Billardon M; Guillou N
Encephale; 1995; 21(2):147-53. PubMed ID: 7781586
[TBL] [Abstract][Full Text] [Related]
31. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
[TBL] [Abstract][Full Text] [Related]
32. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
33. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
[TBL] [Abstract][Full Text] [Related]
34. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
[TBL] [Abstract][Full Text] [Related]
35. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Morton S; Lader M
Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
37. Effects of lorazepam on hyperactivity in ratarded children.
Walters A; Singh N; Beale IL
N Z Med J; 1977 Nov; 86(600):473-5. PubMed ID: 24194
[TBL] [Abstract][Full Text] [Related]
38. Lorazepam in gastrointestinal disorders with anxiety overlay.
Furtado JD
Psychosomatics; 1976; 17(1):32-4. PubMed ID: 5745
[No Abstract] [Full Text] [Related]
39. Double-blind crossover comparison of triazolam and lorazepam in the posthypnotic state.
Cohn JB
J Clin Psychiatry; 1984 Mar; 45(3):104-7. PubMed ID: 6142034
[TBL] [Abstract][Full Text] [Related]
40. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
